AzTrials
AzTrials

Separation Anxiety DisorderNCT00255112

TAFF-Psychological Treatment of Separation Anxiety Disorder

A study testing family based cognitive behavior therapy in people with Separation Anxiety Disorder, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether a specific family based cognitive behavioral treatment program is effective in the treatment of children with separation anxiety disorder. Read more about this study

Who is it for?
Ages 5 to 13 years
Conditions the study is for
Separation Anxiety Disorder
What is being tested?
family based cognitive behavior therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteSwitzerland
Study dates
Jun 2004to Dec 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Primary diagnosis of SAD
  • Age 5 to 13 years
  • Knowledge of German language
  • Consent to randomization and psychological testing

Who cannot join

  • Comorbid Pervasive Developmental Disorders
  • Active psychotropic drugs

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Institute of Psychology

    Basel, Canton of Basel-City, 4055

Other trials in Switzerland

About this study

Official title: Psychological Treatment of Separation Anxiety Disorder

The purpose of this study is to determine whether a specific family based cognitive behavioral treatment program is effective in the treatment of children with separation anxiety disorder.

Read the detailed description

Anxiety disorders are the most common mental disorders both in adulthood and childhood. Recent research indicates that anxiety disorders in childhood and in particular Separation Anxiety Disorder (SAD) increase the risk of mental disorders in adulthood. Despite these results research on SAD is still limited compared to the vast research activity on adult anxiety disorders. The proposed research program will close a gap of current international research: It will test the efficacy of a family based cognitive behavioral treatment program specific for SAD.

The research program consists of two parts. One study is aimed at children with SAD aged 5 to 7. 40 children are randomly allocated immediately to SAD-specific family-based treatment or to a wait list. For the second study 60 children with SAD (8 to 13 years old) are randomly allocated to either SAD-specific family-based treatment ("SAD-CBT") or a well established global CBT program for childhood anxiety disorders ("global CBT").

In both studies treatment success is tested at the end of treatment as well as 4 weeks and 1, 2 and 3 years after treatment.

Being tested
family based cognitive behavior therapy
Keywords
SAD, treatment, cognitive behavior therapy, family, children, anxiety
Medical subject headings
Anxiety, Separation, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • family based cognitive behavior therapyBehavioural

    newly developed family based cognitive behavior therapy for children with separation anxiety disorder over 5 years old

Study groups in NCT00255112
Study groupRoleWhat they receive
1No interventionThe present study evaluates the efficacy of a family-based CBT treatment specifically tailored to children with SAD, developed at the University of Basel. The study consists of 40 participants (5-7 years old) with SAD and their families. Participants were randomly assigned to 12 weeks of SAD-specific family-based CBT treatment or to waitlist condition.
2Active comparatorThe present study evaluates the efficacy of a family-based CBT treatment specifically tailored to children with SAD, developed at the University of Basel in comparison to a global CBT treatment. The study consists of 60 participants (between 8 and 13 years old), randomly assigned to one of the two treatments.
Receives: Behavioral: family based cognitive behavior therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DSM-IV criteria for Separation Anxiety Disorder

    Measured: December 2009

  2. Global Success Rating (GSR)

    Measured: December 2009

  3. Separation Anxiety Inventory for Children (SAI)

    Measured: December 2009

Secondary outcomes (3)
  1. Revised Children's Manifest Anxiety Scale (RCMAS)

    Measured: December 2009

  2. Sheehan Disability Scale (SDS)

    Measured: December 2009

  3. Inventory for the Assessment of Quality of Life in Children and Adolescents (IQL)

    Measured: December 2009

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2005 (estimated)
  2. Study startJun 2004
  3. Primary completionDec 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00255112
Sponsor's protocol ID
PP001--68701
Other IDs
Trennungsangstprojekt NZX 1303
Status last verified
Jun 2015
First submitted
16 Nov 2005
Last updated
11 Jun 2015
Results posted
No
Data monitoring committee
No

Publications

  • Schneider S, Blatter-Meunier J, Herren C, Adornetto C, In-Albon T, Lavallee K. Disorder-specific cognitive-behavioral therapy for separation anxiety disorder in young children: a randomized waiting-list-controlled trial. Psychother Psychosom. 2011;80(4):206-15. doi: 10.1159/000323444. Epub 2011 Apr 14.

    PubMed 21494062

Questions about this trial

What is this clinical trial studying?

A study testing family based cognitive behavior therapy in people with Separation Anxiety Disorder, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DSM-IV criteria for Separation Anxiety Disorder (time frame: December 2009). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00255112, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in